{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Albuterol+HFA", "query": { "intervention": "Albuterol HFA" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 71, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Albuterol+HFA&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-13T14:15:11.433Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02031640", "title": "A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Beclomethasone dipropionate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Albuterol/salbutamol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1113, "start_date": "2013-12", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-09-13T14:15:11.433Z", "location_count": 94, "location_summary": "Costa Mesa, California • Huntington Beach, California • Long Beach, California + 77 more", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02031640" }, { "nct_id": "NCT01019694", "title": "Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Combivent CFC-MDI", "type": "DRUG" }, { "name": "Combivent Respimat 20/100 mcg", "type": "DRUG" }, { "name": "Atrovent HFA 42 mcg + Albuterol HFA 200 mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 470, "start_date": "2009-11", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-10-23", "last_synced_at": "2026-09-13T14:15:11.433Z", "location_count": 55, "location_summary": "Jasper, Alabama • Mobile, Alabama • Mesa, Arizona + 47 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Berkeley", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01019694" }, { "nct_id": "NCT00308685", "title": "Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 95, "start_date": "2006-06-10", "completion_date": "2006-12-04", "has_results": true, "last_update_posted_date": "2022-04-01", "last_synced_at": "2026-09-13T14:15:11.433Z", "location_count": 14, "location_summary": "Little Rock, Arkansas • Huntington Beach, California • San Jose, California + 11 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Huntington Beach", "state": "California" }, { "city": "San Jose", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00308685" }, { "nct_id": "NCT02584257", "title": "Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Mild Persistent Asthma" ], "interventions": [ { "name": "methacholine chloride", "type": "OTHER" }, { "name": "placebo ProAir HFA", "type": "DRUG" }, { "name": "ProAir HFA", "type": "DRUG" }, { "name": "Lupin albuterol HFA MDI", "type": "DRUG" }, { "name": "placebo Lupin albuterol HFA MDI", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Lupin, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 217, "start_date": "2016-04", "completion_date": "2016-09", "has_results": true, "last_update_posted_date": "2020-12-04", "last_synced_at": "2026-09-13T14:15:11.433Z", "location_count": 17, "location_summary": "Huntington Beach, California • Mission Viejo, California • Rolling Hills Estates, California + 14 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Jose", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02584257" }, { "nct_id": "NCT02024204", "title": "Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Lung Diseases", "Medication Compliance" ], "interventions": [ { "name": "Fluticasone propionate 230mcg for 3 Months", "type": "DRUG" }, { "name": "Current Treatment or no treatment", "type": "DRUG" }, { "name": "Salmeterol 21mcg for 3 Months", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 60, "start_date": "2014-04-09", "completion_date": "2017-05-17", "has_results": true, "last_update_posted_date": "2021-02-02", "last_synced_at": "2026-09-13T14:15:11.433Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02024204" }, { "nct_id": "NCT00685425", "title": "Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma", "Bronchoconstriction" ], "interventions": [ { "name": "Levalbuterol HFA MDI", "type": "DRUG" }, { "name": "Racemic Albuterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 62, "start_date": "2002-10", "completion_date": "2003-03", "has_results": false, "last_update_posted_date": "2012-02-22", "last_synced_at": "2026-09-13T14:15:11.433Z", "location_count": 5, "location_summary": "Los Angeles, California • Signal Hill, California • Denver, Colorado + 2 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Signal Hill", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Burke", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00685425" }, { "nct_id": "NCT00400608", "title": "A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "ADVAIR HFA", "type": "DRUG" }, { "name": "ADVAIR DISKUS", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 28, "start_date": "2006-10", "completion_date": "2007-02", "has_results": false, "last_update_posted_date": "2016-10-28", "last_synced_at": "2026-09-13T14:15:11.433Z", "location_count": 3, "location_summary": "Huntington Beach, California • Long Beach, California • Medford, Oregon", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Medford", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00400608" }, { "nct_id": "NCT01056159", "title": "A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol dry powder inhaler", "type": "DRUG" }, { "name": "Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 47, "start_date": "2010-01", "completion_date": "2010-06", "has_results": false, "last_update_posted_date": "2022-02-02", "last_synced_at": "2026-09-13T14:15:11.433Z", "location_count": 9, "location_summary": "Los Angeles, California • Denver, Colorado • Lakewood, Colorado + 5 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Lakewood", "state": "Colorado" }, { "city": "Normal", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01056159" }, { "nct_id": "NCT00684866", "title": "Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Levalbuterol HFA MDI followed by Racemic albuterol HFA MDI", "type": "DRUG" }, { "name": "Racemic Albuterol followed by levalbuterol HFA MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 31, "start_date": "2003-01", "completion_date": "2003-07", "has_results": false, "last_update_posted_date": "2012-02-22", "last_synced_at": "2026-09-13T14:15:11.433Z", "location_count": 11, "location_summary": "Madera, California • San Diego, California • Savannah, Georgia + 8 more", "locations": [ { "city": "Madera", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Savannah", "state": "Georgia" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Cortland", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00684866" }, { "nct_id": "NCT01189396", "title": "Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma", "Bronchospasm", "Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "A006", "type": "DRUG" }, { "name": "Placebo DPI", "type": "DRUG" }, { "name": "Proventil-HFA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amphastar Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 27, "start_date": "2010-07", "completion_date": "2011-01", "has_results": false, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-09-13T14:15:11.433Z", "location_count": 4, "location_summary": "Medford, Oregon • Portland, Oregon • San Antonio, Texas + 1 more", "locations": [ { "city": "Medford", "state": "Oregon" }, { "city": "Portland", "state": "Oregon" }, { "city": "San Antonio", "state": "Texas" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01189396" } ] }